title: Switching from a vitamin K antagonist to a NOAC.
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, B18 7QH, UK.
authors.forename: Keitaro
authors.initials: K
authors.lastname: Senoo
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, B18 7QH, UK; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: g.y.h.lip@bham.ac.uk.
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy; D006801:Humans; D020521:Stroke / Q000188:drug therapy; D014812:Vitamin K / Q000037:antagonists & inhibitors*
chemical_list: D000925:Anticoagulants; D014812:Vitamin K